STSidharth Tyagi

Sidharth Tyagi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sidharth Tyagi has a total of 65 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Combined Nav1.7–Nav1.8 channel abrogation: Supralinear suppression of excitability in a subpopulation of peripheral sensory neurons

    by Dmytro Vasylyev, Sidharth Tyagi, Mohammad-Reza Ghovanloo, Peng Zhao, Stephen G. Waxman

    There is a pressing need for nonaddictive pain therapeutics. Despite the genetic validation of peripheral voltage-gated sodium (Nav) channels as targets for non-opioid pain therapy, isoform-selective inhibition of Nav1.7 and Nav1.8 has yielded limited efficacy in clinical studies, with Nav1.8 blockade providing statistically significant but only partial pain relief. This raises the question: if block of Nav1.8 relieves pain only partially, what is needed for better pain relief? In this study, we utilized dynamic clamp, which permits precisely calibrated functional addition or subtraction of the current from any given channel, to systematically interrogate the combinatorial landscape of multiplex abrogation of currents from Nav1.7 and Nav1.8, both major contributors to electrogenesis within dorsal root ganglion neurons. We demonstrate that partial, simultaneous attenuation of both conductances drives a supralinear increase in current threshold in many sensory neurons. Responses to Nav1.8 functional subtraction span a broad spectrum, whereas responses to Nav1.7 subtraction are comparatively uniform. Neurons with greater sensitivity to functional loss of Nav1.8 show greater suppression of excitability during combined Nav1.7–Nav1.8 attenuation, while weak Nav1.8 responders remain comparatively resistant. These findings identify electrogenic dependence on Nav1.8 as a major source of functional heterogeneity in sensory neurons and demonstrate that Nav1.7 acts cooperatively with Nav1.8 to shape the consequences of channel attenuation. Our results indicate that combined Nav1.7–Nav1.8 targeting should outperform isoform-selective block in suppressing firing in a subpopulation of pain-signaling neurons, while not producing universal suppression.

  • Open Access

    Combinatorial logic of Nav channels in nociceptor excitability: Different degrees of synergy define distinct neuronal groups

    by Dmytro Vasylyev, Sidharth Tyagi, Mohammad-Reza Ghovanloo, Peng Zhao, Stephen G. Waxman

    Despite the genetic validation of voltage-gated sodium (Nav) channels as targets for pain therapy, single-channel subtype inhibition in clinical trials has yielded limited efficacy. Because Nav1.7 and Nav1.8 are thought to act in a coupled manner in ignition and subsequent regenerative, overshooting depolarization underlying the action potential of nociceptors, we utilized dynamic clamp, which permits precisely calibrated addition or subtraction of the current from any given channel, to systematically interrogate their combinatorial landscape. We demonstrate that nociceptor excitability is governed by highly non-linear biophysical rules. Partial, simultaneous attenuation of both conductances drives a supralinear collapse of action potential electrogenesis in sensory neurons. Unsupervised clustering reveals that this synergistic vulnerability is not a continuum, but varies in different neuronal subtypes: a population of sensory neurons experiences profound excitability suppression, whereas another population remains relatively resistant. These non-linear boundaries demonstrate that the efficacy of Nav current abrogation is fundamentally restricted by the underlying electrogenic architecture of the neuron, and provide a mechanistic blueprint for subtype-selective silencing.


  • Open Access

    Nav1.8 Variant I206M as a Latent Susceptibility Factor in Postaxotomy Ocular Pain

    by Mohammad-Reza Ghovanloo, Philip R. Effraim, Sidharth Tyagi, Alecia M. Aldrich, Jun-Hui Yuan, Betsy R. Schulman, Deborah S. Jacobs, Sulayman D. Dib-Hajj, Stephen G. Waxman

    A small proportion of patients develop persistent ocular pain after corneal refractive surgery, which injures the distal axons of trigeminal ganglia neurons innervating the eye. In this study, we investigate the role of a low-frequency Nav1.8 variant, c.618A > G (p.I206M), in the pathogenesis of persistent ocular pain after corneal refractive surgery. Whole-exome sequencing in a cohort of patients with post-LASIK ocular pain identified c.618A > G (p.I206M) in SCN10A. We characterized its functional effects using patch-clamp electrophysiology, computer simulations, and multielectrode array recordings of transfected rat trigeminal neurons. p.I206M produced a hyperpolarizing shift in activation of ∼5 mV without significant effects on current density, inactivation, persistent currents, or recovery kinetics. Modeling predicted a small increase in excitability, attenuated under simulated heterozygous conditions. MEA recordings indicated a significant increase in firing frequency in trigeminal neuron firing at 33 and 37°C for p.I206M vs reference (wild-type) neurons. Although subtle, the p.I206M activation shift may lower the excitability threshold of trigeminal neurons. In the context of axotomy-induced remodeling of the electrogenisome, such variants may act as latent susceptibility factors for chronic ocular pain. Together with prior findings of Nav1.7, TRPV1, and TRPM8 variants in this same cohort, these results support a multihit model, in which rare gain-of-function ion channel variants combine with nerve injury to drive persistent pain after injury, in this instance a second injury, to distal trigeminal axons. Given recent clinical validation of Nav1.8 as an analgesic target, this work further highlights the translational significance of Nav1.8 in human pain disorders.


  • ImmunoStruct enables multimodal deep learning for immunogenicity prediction

    by Kevin Bijan Givechian, João Felipe Rocha, Chen Liu, Edward Yang, Sidharth Tyagi, Kerrie Greene, Rex Ying, Etienne Caron, Akiko Iwasaki, Smita Krishnaswamy


  • Altered Gating of Two Ca V 2.1 Variants Linked to Neurodevelopmental Disorders With Epilepsy and Migraine

    by Ulises Meza, Catalina Romero‐Méndez, Danira A. Ramírez‐De León, Hugo Bibollet, Sidharth Tyagi, Pradnya Bhadane, Symeon Papadopoulos, Mario F. Salamanca‐Vera, Jose Manuel Perez‐Aguilar, Michael F. Wangler, et al.

    P/Q‐type (Ca V 2.1) Ca 2+ channels regulate the release of neurotransmitter at central synapses. Missense and nonsense mutations in CACNA1A , the gene that encodes the principal α 1A subunit of the Ca V 2.1 channel complex, are well‐known to cause Episodic Ataxia type 2 (EA2) and Familial Hemiplegic Migraine type 1 (FHM1). These Ca V 2.1 channelopathies are typically caused by either channel loss/reduction‐of‐function (LOF) or gain‐of‐function (GOF), respectively. However, recent genome‐wide sequencing has revealed that point mutations in Ca V 2.1, in fact, underlie a spectrum of neurological disorders that feature epilepsy, tremor, nystagmus, hypotonia, cerebellar atrophy, cognitive deficits, and global developmental delay. Given the multiple manifestations of the mutations and the broad range of severity among these disorders, the assessment of the impact of an individual pathological mutation on channel function is essential for understanding the etiology of a given case. To this end, we expressed the rat orthologues of one newly identified and one previously reported, but yet to be characterized, human Ca V 2.1 variants (V176M and R1673C, respectively) in HEK 293 cells and investigated their biophysical properties using patch‐clamp electrophysiology. The corresponding rat variants (V178M and R1624C, respectively) had multiple effects on channel function, though each mutation affected channel gating differently. V178M displayed a ~10 mV hyperpolarizing shift in activation and slowed deactivation, while R1624C slowed channel activation kinetics, delayed closure, and accelerated recovery from inactivation. Molecular modeling revealed structural alterations that may account for the observed changes in channel gating. Taken together, our results indicate that V176M and R1673C likely cause human Ca V 2.1 channelopathies through multiple, distinct mechanisms.

  • High-throughput multiplex voltage-clamp/current-clamp evaluation of acutely isolated neurons

    by Mohammad-Reza Ghovanloo, Sidharth Tyagi, Peng Zhao, Emre Kiziltug, Mark Estacion, Philip R. Effraim, Sulayman D. Dib-Hajj, Stephen G. Waxman

    The patch-clamp technique remains the gold-standard for the investigation of excitable cells. However, the manual implementation of this technique is slow and low throughput. While recently developed high-throughput robotic patch-clamp methods have proven valuable for drug screening, they have predominantly focused on investigating receptors and channels overexpressed in heterologous cell lines. We recently developed an automated high-throughput patch-clamp approach that enables the simultaneous and unbiased analysis of acutely dissociated neurons in their native state. To analyze and manage the large and complex datasets resulting from this methodology, we have also developed open-source software with an easy-to-use graphical user interface to fit data from each neuron with appropriate biophysical equations to functionally characterize each individual neuron. Here we describe a protocol that provides a streamlined set of procedures, including (1) the dissociation and isolation of neurons from intact tissue; (2) the designing and performing of patch-clamp experiments on the robotic system; and (3) the analysis of data using predetermined, unbiased filtration criteria. This methodology can be used for diverse applications ranging from the assessment of neuronal biophysics to drug development. The protocol requires 6–18 h including cell preparation, experimental execution and analysis of the generated data. Graduate-student-level expertise in animal dissection, electrophysiology and biophysics is required.


  • Sculpting excitable membranes: voltage-gated ion channel delivery and distribution

    by Sidharth Tyagi, Grant P. Higerd-Rusli, Elizabeth J. Akin, Stephen G. Waxman, Sulayman D. Dib-Hajj

    The polarized and domain-specific distribution of membrane ion channels is essential for neuronal homeostasis, but delivery of these proteins to distal neuronal compartments (such as the axonal ends of peripheral sensory neurons) presents a logistical challenge. Recent developments have enabled the real-time imaging of single protein trafficking and the investigation of the life cycle of ion channels across neuronal compartments. These studies have revealed a highly regulated process involving post-translational modifications, vesicular sorting, motor protein-driven transport and targeted membrane insertion. Emerging evidence suggests that neuronal activity and disease states can dynamically modulate ion channel localization, directly influencing excitability. This Review synthesizes current knowledge on the spatiotemporal regulation of ion channel trafficking in both central and peripheral nervous system neurons. Understanding these processes not only advances our fundamental knowledge of neuronal excitability, but also reveals potential therapeutic targets for disorders involving aberrant ion channel distribution, such as chronic pain and neurodegenerative diseases.


  • Open Access

    Targeted ubiquitination of Na V 1.8 reduces sensory neuronal excitability

    by Sidharth Tyagi, Mohammad-Reza Ghovanloo, Matthew Alsaloum, Philip Effraim, Grant P. Higerd-Rusli, Fadia Dib-Hajj, Peng Zhao, Shujun Liu, Stephen G. Waxman, Sulayman D. Dib-Hajj

    Chronic pain and addiction are a significant global health challenge. Voltage-gated sodium channel Na V 1.8, a pivotal driver of pain signaling, is a clinically validated target for the development of novel, non-addictive pain therapeutics. Small molecule inhibitors against Na V 1.8 have shown promise in acute pain indications, but large clinical effect sizes have not yet been demonstrated and efficacy in chronic pain indications are lacking. An alternative strategy to target Na V 1.8 channels for analgesia is to reduce the number of channels that are present on nociceptor membranes. We generated a therapeutic heterobifunctional protein, named UbiquiNa V , that contains a Na V 1.8-selective binding module and the catalytic subunit of the NEDD4 E3 Ubiquitin ligase. We show that UbiquiNav significantly reduces channel expression in the plasma membrane and reduces Na V 1.8 currents in rodent sensory neurons. We demonstrate that UbiquiNa V is selective for Na V 1.8 over other Na V isoforms and other components of the sensory neuronal electrogenisome. We then show that UbiquiNa V normalizes the distribution of Na V 1.8 protein to distal axons, and that UbiquiNa V normalizes the neuronal hyperexcitability in in vitro models of inflammatory and chemotherapy-induced neuropathic pain. Our results serve as a blueprint for the design of therapeutics that leverage the selective ubiquitination of Na V 1.8 channels for analgesia.


  • Top Cited Papers
    Open Access

    Nav1.8, an analgesic target for nonpsychotomimetic phytocannabinoids

    by Mohammad-Reza Ghovanloo, Sidharth Tyagi, Peng Zhao, Stephen G. Waxman

    Pain impacts billions of people worldwide, but treatment options are limited and have a spectrum of adverse effects. The search for safe and nonaddictive pain treatments has led to a focus on key mediators of nociceptor excitability. Voltage-gated sodium (Nav) channels in the peripheral nervous system—Nav1.7, Nav1.8, and Nav1.9—play crucial roles in pain signaling. Among these, Nav1.8 has shown promise due to its rapid recovery from inactivation and role in repetitive firing, with recent clinical studies providing proof-of-principal that block of Nav1.8 can reduce pain in humans. We report here that three nonpsychotomimetic cannabinoids—cannabidiol (CBD), cannabigerol (CBG), and cannabinol (CBN)—effectively inhibit Nav1.8, suggesting their potential as analgesic compounds. In particular, CBG shows significant promise due to its ability to effectively inhibit excitability of peripheral sensory neurons. These findings highlight the therapeutic potential of cannabinoids, particularly CBG, as agents that may attenuate pain via block of Nav1.8, warranting further in vivo studies.


  • Open Access

    TRPM8 Mutations Associated With Persistent Pain After Surgical Injury of Corneal Trigeminal Axons

    by Mohammad-Reza Ghovanloo, Philip R. Effraim, Sidharth Tyagi, Alecia M. Aldrich, Xiaoyang Cheng, Jun-Hui Yuan, Betsy R. Schulman, Deborah S. Jacobs, Sulayman D. Dib-Hajj, Stephen G. Waxman

    Despite extensive efforts, the mechanisms underlying pain after axonal injury remain incompletely understood. Pain following corneal refractive surgery offers a valuable human model for investigating trigeminal axonal injury because laser-assisted in situ keratomileusis (LASIK) severs axons of trigeminal ganglion neurons innervating the cornea. While the majority of patients are pain-free shortly after surgery, a minority endure persistent postoperative ocular pain. Through genomic analysis of patients experiencing persistent postoperative ocular pain, we identified rare variants in genes encoding ion channels and receptors, including TRPM8, which codes for the menthol-sensitive and cold-sensing transient receptor potential cation channel. We conducted a profiling of 2 TRPM8 mutant variants, D665N and V915M, which were identified in patients suffering from persistent pain after LASIK surgery. We used patch-clamp and multielectrode array (MEA) recordings to investigate the biophysical and pharmacologic properties of mutant vs wild-type (WT) channels. Patch-clamp analysis shows that these mutations shift the activation curves of TRPM8 in a hyperpolarized direction, with this effect being significantly different between WT and D665N channels. In addition, both mutations significantly increase channel sensitivity to the canonical ligand, menthol. MEA recordings from transfected rat trigeminal ganglion neurons indicate that expression of D665N and V915M mutant channels increases spontaneous activity compared with WT channels. Consistent with patch-clamp results, neuronal activity in MEA recordings was increased on exposure to menthol. Collectively, our findings suggest that proexcitatory mutations of TRPM8, in the context of axonal injury within the cornea, can produce trigeminal ganglion neuron hyperexcitability that contributes to persistent postoperative ocular pain. In addition to providing additional evidence for a role of TRPM8 in human pain, our results suggest that inhibitors of this channel merit future study.